105 related articles for article (PubMed ID: 1818592)
1. [Differentiation activity of pyridoxal thiosemicarbazone and its copper and cobalt complexes on Friend erythroleukemia cells].
Albertini R; Gasparri Fava G; Pinelli S; Tarasconi P; Starcich B
Boll Soc Ital Biol Sper; 1991 Jul; 67(7):673-80. PubMed ID: 1818592
[TBL] [Abstract][Full Text] [Related]
2. Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activity.
Casas JS; Rodríguez-Argüelles MC; Russo U; Sánchez A; Sordo J; Vázquez-López A; Pinelli S; Lunghi P; Bonati A; Albertini R
J Inorg Biochem; 1998 Mar; 69(4):283-92. PubMed ID: 9654752
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride.
Belicchi Ferrari M; Gasparri Fava G; Tarasconi P; Albertini R; Pinelli S; Starcich R
J Inorg Biochem; 1994 Jan; 53(1):13-25. PubMed ID: 8133248
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and biological activity of copper complexes with pyridoxal thiosemicarbazone derivatives. X-ray crystal structure of three dimeric complexes.
Belicchi Ferrari M; Bisceglie F; Pelosi G; Tarasconi P; Albertini R; Dall'Aglio PP; Pinelli S; Bergamo A; Sava G
J Inorg Biochem; 2004 Feb; 98(2):301-12. PubMed ID: 14729310
[TBL] [Abstract][Full Text] [Related]
5. Copper(II) and cobalt(III) pyridoxal thiosemicarbazone complexes with nitroprusside as counterion: syntheses, electronic properties, and antileukemic activity.
Belicchi-Ferrari M; Bisceglie F; Casoli C; Durot S; Morgenstern-Badarau I; Pelosi G; Pilotti E; Pinelli S; Tarasconi P
J Med Chem; 2005 Mar; 48(5):1671-5. PubMed ID: 15743209
[TBL] [Abstract][Full Text] [Related]
6. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
7. Ureido derivatives of pyridine: a new class of inducers of murine erythroleukemia cell differentiation.
Pappas IS; Niopas I; Tsiftsoglou AS
Anticancer Drug Des; 1992 Apr; 7(2):153-61. PubMed ID: 1575888
[TBL] [Abstract][Full Text] [Related]
8. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells.
Lo SC; Aft R; Mueller GC
Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076
[TBL] [Abstract][Full Text] [Related]
9. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of erythroid differentiation of mouse erythroleukemia cells by a macrophage product(s).
Sassa S; Wolpe S; Cerami A
Blood Cells; 1987; 13(1-2):161-9. PubMed ID: 3478107
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and spectroscopic properties of copper(II) complexes derived from thiophene-2-carbaldehyde thiosemicarbazone. Structure and biological activity of [Cu(C6H6N3S2)2].
García-Tojal J; García-Orad A; Serra JL; Pizarro JL; Lezama L; Arriortua MI; Rojo T
J Inorg Biochem; 1999 May; 75(1):45-54. PubMed ID: 10402676
[TBL] [Abstract][Full Text] [Related]
12. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
Ruscetti SK
J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
[TBL] [Abstract][Full Text] [Related]
13. Complexes of 2-acetyl-gamma-butyrolactone and 2-furancarbaldehyde thiosemicarbazones: antibacterial and antifungal activity.
Rodríguez-Argüelles MC; Tourón-Touceda P; Cao R; García-Deibe AM; Pelagatti P; Pelizzi C; Zani F
J Inorg Biochem; 2009 Jan; 103(1):35-42. PubMed ID: 18947878
[TBL] [Abstract][Full Text] [Related]
14. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
Sherman ML; Shafman TD; Kufe DW
J Cell Physiol; 1988 Mar; 134(3):429-36. PubMed ID: 2450878
[TBL] [Abstract][Full Text] [Related]
16. Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity.
Rodriguez-Argüelles MC; Belicchi Ferrari M; Gasparri Fava G; Pelizzi C; Pelosi G; Albertini R; Bonati A; Dall'Aglio PP; Lunghi P; Pinelli S
J Inorg Biochem; 1997 Apr; 66(1):7-17. PubMed ID: 9076969
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of leukemic cell lines: a review focusing on murine erythroleukemia and human HL-60 cells.
Tsiftsoglou AS; Robinson SH
Int J Cell Cloning; 1985 Nov; 3(6):349-66. PubMed ID: 3905996
[TBL] [Abstract][Full Text] [Related]
18. Induction of differentiation of Friend murine erythroleukemia cells by poly-L-lysine and daunorubicin-poly-L-lysine conjugate.
Supino R; Gibelli N; Zunino F
J Natl Cancer Inst; 1986 Aug; 77(2):453-7. PubMed ID: 3461206
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
[TBL] [Abstract][Full Text] [Related]
20. Morphological changes in erythroblasts during erythropoietin-induced terminal differentiation in vitro.
Koury ST; Koury MJ; Bondurant MC
Exp Hematol; 1988 Oct; 16(9):758-63. PubMed ID: 3169158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
